Executive Vice President, CSL Behring Operations
Mary Sontrop is responsible for CSL Behring’s Marburg (Germany), Bern (Switzerland) and Kankakee (US) state-of-the-art manufacturing facilities where the company’s lifesaving biotherapies are produced. She is based in King of Prussia.
Since joining CSL Limited in 1988, Ms. Sontrop held a broad range of positions in Australia and Europe during CSL’s rapid international growth. Ms. Sontrop was involved in the acquisitions of ZLB in 2000 and Aventis Behring in 2004. At ZLB in Bern, Ms. Sontrop became Head of Quality Management, Assurance and Control in 2000 and was later appointed Chief Operating Officer. Ms. Sontrop also previously headed CSL Behring’s manufacturing facilities in Marburg.
Most recently, Ms. Sontrop served as General Manager, CSL Biotherapies Australia, having been appointed in 2006. In that role, she was responsible for the company’s vaccines and pharmaceuticals business and provided operational support for global sales of influenza vaccines manufactured by CSL.
Ms. Sontrop received a Bachelor of Applied Science, a Master of Business Administration, and has graduate diplomas in Health Administration and Quality Management.
Return to Top